Who owns ALNYLAM PHARMACEUTICALS, INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ALNY from SEC Form 13F filings across 728 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 728 institutions disclosed 135.5M shares of ALNYLAM PHARMACEUTICALS, INC. worth $33.42B — about 101.3% of shares outstanding; the largest disclosed holder is Capital World Investors. Source: SEC Form 13F filings, parsed by EvidInvest.
728
13F holders
$33.42B
value, 2026 filers
101.3%
of shares outstanding (135.5M sh)
97
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of ALNY's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Capital World Investors | 13.8M | $3.41B | 0.4% | 10.3% | +24.0% |
| 2 | FMR LLC | 12.6M | $3.11B | 0.1% | 9.4% | -16.0% |
| 3 | BlackRock, Inc. | 11.0M | $2.72B | 0.0% | 8.2% | +1.0% |
| 4 | Capital Research Global Investors | 10.9M | $2.70B | 0.4% | 8.2% | +12.2% |
| 5 | T. Rowe Price Investment Management, Inc. | 10.0M | $2.47B | 1.7% | 7.5% | +77.4% |
| 6 | VANGUARD PORTFOLIO MANAGEMENT LLC | 6.7M | $1.65B | 0.1% | 5% | +2.4% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 6.0M | $1.48B | 0.0% | 4.5% | -0.2% |
| 8 | BAILLIE GIFFORD & CO | 5.5M | $1.36B | 1.3% | 4.1% | +125.1% |
| 9 | STATE STREET CORP | 3.8M | $941.9M | 0.0% | 2.9% | +7.4% |
| 10 | Invesco Ltd. | 3.7M | $922.3M | 0.1% | 2.8% | -0.4% |
| 11 | WELLINGTON MANAGEMENT GROUP LLP | 3.5M | $858.3M | 0.2% | 2.6% | +64.8% |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 2.6M | $637.3M | 0.0% | 1.9% | -1.7% |
| 13 | Orbis Allan Gray Ltd | 2.4M | $597.4M | 2.0% | 1.8% | +21.8% |
| 14 | Dodge & Cox | 2.0M | $495.1M | 0.3% | 1.5% | +2.6% |
| 15 | BANK OF AMERICA CORP /DE/ | 1.7M | $427.4M | 0.0% | 1.3% | +74.2% |
| 16 | JPMORGAN CHASE & CO | 1.7M | $437.6M | 0.0% | 1.3% | -35.6% |
| 17 | AQR CAPITAL MANAGEMENT LLC | 1.7M | $419.4M | 0.1% | 1.3% | +133.5% |
| 18 | Clearbridge Investments, LLC | 1.3M | $323.8M | 0.3% | 1% | +4.2% |
| 19 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 1.2M | $284.2M | 0.2% | 0.9% | +28.9% |
| 20 | D. E. Shaw & Co., Inc. | 1.1M | $267.1M | 0.1% | 0.8% | -2.0% |
| 21 | MORGAN STANLEY | 1.1M | $261.6M | 0.0% | 0.8% | +2.7% |
| 22 | AMERICAN CENTURY COMPANIES INC | 1.0M | $249.2M | 0.1% | 0.8% | -45.5% |
| 23 | Legal & General Group Plc | 912,129 | $225.1M | 0.0% | 0.7% | -1.3% |
| 24 | NORTHERN TRUST CORP | 911,073 | $224.8M | 0.0% | 0.7% | +2.7% |
| 25 | ROYAL BANK OF CANADA | 883,125 | $217.9M | 0.0% | 0.7% | +0.8% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.